Yuanyuan Si

Also affiliated with AstraZeneca (United States)

ChemistryMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cell-Free Biosynthesis to Evaluate Lasso Peptide Formation and Enzyme-Substrate Tolerance”.

Cell-Free Biosynthesis to Evaluate Lasso Peptide Formation and Enzyme-Substrate Tolerance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.25.399105

N/A

0DataRank · unranked

5 citations

Ashley M. Kretsch, Laura M. Daigh, Mark J. Burk, Douglas A. Mitchell, Yuanyuan Si

Heterobivalent Inhibitors of Acetyl-CoA Carboxylase: Drug Target Residence Time and Time-Dependent Antibacterial Activity

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c01380

N/A

0DataRank · unranked

8 citations

YongLe He, Rajeswari Basu, Nan Wang, Shabnam Davoodi, Lauren A. Spagnuolo +6 more

Peptidase Activation by a Leader Peptide-Bound RiPP Recognition Element

Biochemistry(2023)10.1021/acs.biochem.2c00700

N/A

0DataRank · unranked

40 citations

Mayuresh G. Gadgil, Adam J. DiCaprio, Susanna E. Barrett, Bryce Kille, Yuanyuan Si +3 more